Boots becomes first UK high street pharmacy to launch medical cannabis service

News

Boots has become the first major UK high street pharmacy to launch a medical cannabis prescribing service, offering patients with chronic pain, anxiety and insomnia access to specialist treatment.

The health and beauty giant has launched SureLeaf through its Boots Online Doctor platform, enabling eligible patients aged 25 and over to access private prescriptions for medical cannabis where conventional treatments have failed to provide adequate relief.

The new service covers a range of conditions, including fibromyalgia, arthritis, chronic back pain, generalised anxiety disorder and insomnia.

Patients will initially complete an online assessment before undergoing a clinical review and video consultation with a specialist consultant registered with the General Medical Council.

Any proposed prescription will then be independently reviewed by a multidisciplinary clinical team, including a second consultant, before treatment begins.

Patients will receive an initial follow-up after 28 days, followed by reviews at least every three months.

Boots chief healthcare officer Jamie Kerruish said: “Medical cannabis is a specialist area of healthcare and, through SureLeaf, we’re giving eligible patients another treatment option to consider, supported by clinical expertise and robust ongoing care.”

The company is also exploring a collaborative research programme with the University of Nottingham to examine patient outcomes, prescribing practices and the role of medical cannabis in managing chronic pain.

Boots Online Doctor medical director Dr David Gwynne said: “Medical cannabis is not appropriate for everyone and prescribing decisions need to be made carefully on an individual patient basis.

“SureLeaf has therefore been designed with strong clinical safeguards and specialist oversight at every stage, so treatment is only considered for patients where it is clinically appropriate.”

Medical cannabis was legalised for specialist prescription in the UK in 2018, although NHS access remains limited and most patients currently obtain treatment through private clinics.

Click here to sign up to Retail Gazette‘s free daily email newsletter

News

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

News

Share:

Boots becomes first UK high street pharmacy to launch medical cannabis service

Boots has become the first major UK high street pharmacy to launch a medical cannabis prescribing service, offering patients with chronic pain, anxiety and insomnia access to specialist treatment.

The health and beauty giant has launched SureLeaf through its Boots Online Doctor platform, enabling eligible patients aged 25 and over to access private prescriptions for medical cannabis where conventional treatments have failed to provide adequate relief.

The new service covers a range of conditions, including fibromyalgia, arthritis, chronic back pain, generalised anxiety disorder and insomnia.

Patients will initially complete an online assessment before undergoing a clinical review and video consultation with a specialist consultant registered with the General Medical Council.

Any proposed prescription will then be independently reviewed by a multidisciplinary clinical team, including a second consultant, before treatment begins.

Patients will receive an initial follow-up after 28 days, followed by reviews at least every three months.

Boots chief healthcare officer Jamie Kerruish said: “Medical cannabis is a specialist area of healthcare and, through SureLeaf, we’re giving eligible patients another treatment option to consider, supported by clinical expertise and robust ongoing care.”

The company is also exploring a collaborative research programme with the University of Nottingham to examine patient outcomes, prescribing practices and the role of medical cannabis in managing chronic pain.

Boots Online Doctor medical director Dr David Gwynne said: “Medical cannabis is not appropriate for everyone and prescribing decisions need to be made carefully on an individual patient basis.

“SureLeaf has therefore been designed with strong clinical safeguards and specialist oversight at every stage, so treatment is only considered for patients where it is clinically appropriate.”

Medical cannabis was legalised for specialist prescription in the UK in 2018, although NHS access remains limited and most patients currently obtain treatment through private clinics.

Click here to sign up to Retail Gazette‘s free daily email newsletter

Social


SUBSCRIBE TO OUR DAILY NEWSLETTER

  • This field is for validation purposes and should be left unchanged.
News

Leave a Reply

Your email address will not be published. Required fields are marked *

Fill out this field
Fill out this field
Please enter a valid email address.

RELATED STORIES

Latest Feature


Menu



Please enter the verification code sent to your email: